EmboCept^®S DSM 50µm
Intended Use / Indication For Use: EmboCept^®S DSM 50 μm suspension for injection is an adjuvant in the intra-arterial treatment of inoperable liver tumours and lung tumours in combination with cytostatic agents, the aim of which is to optimise the intra-tumoral drug accumulation. Consult the Instructions for Use for a complete listing of indications, contraindications, side effects, warnings, and precautions. March 2025

EmboCept^® is a registered trademark of Magle PharmaCept GmbH.

Manufacturer
Magle Chemoswed AB, Agneslundsvägen 27, SE-212 15 Malmö, Sweden Phone: +46 (0)40 38 33 00, www.maglechemoswed.com Distributed by Sirtex Medical Pty Ltd Shop 6, 207 Pacific Highway St Leonards, NSW 2065 Australia Tel: +61 2 9964 8400 Fax: +61 2 9964 8410

EmboCept^® is a registered trademark of Magle PharmaCept GmbH.

SIR-Spheres^® Y-90 resin microspheres
Intended Purpose: SIR-Spheres^® Y-90 resin microspheres are intended for Brachytherapy and are permanently implanted via the hepatic artery to deliver therapy to hepatic tumors. Indications For Use: SIR-Spheres^® Y-90 resin microspheres are indicated for the treatment of unresectable hepatocellular carcinoma (HCC) or unresectable metastatic liver tumors from primary colorectal cancer (mCRC) in patients refractory to or intolerant of chemotherapy.
Consult the Instructions for Use (www.sirtex.com) for a complete listing of indications, contraindications, warnings, precautions, adverse events and risks. March 2025

Manufacturer
Sirtex Medical Pty Ltd Shop 6, 207 Pacific Highway St Leonards NSW 2065 Australia Tel: +61 2 9964 8400 Fax: +61 2 9964 8410 Europe, Middle East & Africa Sirtex Medical Europe GmbH Joseph-Schumpeter-Allee 33 53227 Bonn Germany Tel: +49 228 1840 730

SIR-Spheres^® is a registered trademark of Sirtex SIR-Spheres Pty Ltd. ©2025 Sirtex Medical Europe GmbH APM-EMEA-005-03-25